Mendelian disorders causing hypertension

2020 ◽  
pp. 3796-3800
Author(s):  
Nilesh J. Samani ◽  
Maciej Tomaszewski

Several rare mendelian disorders where hypertension is the predominant manifestation have been characterized at the molecular level. These include glucocorticoid-remediable aldosteronism, the syndrome of apparent mineralocorticoid excess, Liddle’s syndrome, and Gordon’s syndrome. Hypertension and hypokalaemia are features of 11β‎-hydroxylase and 17β‎-hydroxylase deficiency—two rare recessive gene disorders of adrenal steroid-synthesizing enzymes that, among others, cause congenital adrenal hyperplasia. 11β‎-Hydroxylase deficiency usually presents in infancy or early childhood with virilization of both sexes, while presentation of 17β‎-hydroxylase deficiency may be delayed until adolescence or adulthood. Hypertension due to a phaeochromocytoma may be a feature of multiple endocrine neoplasia type 2 (MEN2, Sipple’s syndrome), which when familial is inherited in an autosomal dominant pattern, or rarely to be a feature of neurofibromatosis (von Recklinghausen’s disease).

2010 ◽  
Vol 163 (6) ◽  
pp. 963 ◽  
Author(s):  
Cristina Romei ◽  
Stefano Mariotti ◽  
Laura Fugazzola ◽  
Augusto Taccaliti ◽  
Furio Pacini ◽  
...  

The journal and the authors apologise for an error in the name of one of the authors (appears as Verga Uberta) of this article published in the European Journal of Endocrinology Vol 163 301–308. The correct name of the author should be Uberta Verga and not as published.


2013 ◽  
Vol 57 (4) ◽  
pp. 312-316 ◽  
Author(s):  
Pedro Weslley Rosário ◽  
Gustavo Cancela Penna ◽  
Kamilla Brandão ◽  
Bárbara Érika Souza

OBJECTIVE: To evaluate the usefulness of preoperative serum calcitonin (sCT) in patients with nodular disease without suspicion of medullary thyroid carcinoma (MTC) in history or cytology. PATIENTS AND METHODS: sCT was measured before thyroidectomy in 494 patients with nodular disease who had no family history of MTC or multiple endocrine neoplasia type 2, and no cytological suspicion of MTC. RESULTS: Basal sCT was < 10 ng/mL in 482 patients and none of them had MTC. One patient with basal sCT > 100 pg/mL had MTC. Among the 11 patients with basal sCT between 10 and 100 pg/mL, MTC was diagnosed in only one. The two patients with MTC were submitted to total thyroidectomy, combined with elective lymph node dissection indicated exclusively based on hypercalcitoninemia, and sCT was undetectable after six months. CONCLUSIONS: Preoperative sCT is useful for the detection of sporadic MTC in patients with nodular disease, even in the absence of suspicious history or cytology.


Sign in / Sign up

Export Citation Format

Share Document